CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
Moins-Teisserenc H, Daubord M, Clave E, Douay C, Félix J, Marie-Cardine A, Ram-Wolff C, Maki G, Beldjord K, Homyrda L, Michel L, Bensussan A, Toubert A, Bagot M.
Moins-Teisserenc H, et al. Among authors: bensussan a.
J Invest Dermatol. 2015 Jan;135(1):247-257. doi: 10.1038/jid.2014.356. Epub 2014 Aug 26.
J Invest Dermatol. 2015.
PMID: 25158034
Free article.